Alligator Bioscience AB (publ)

OM:ATORX Stock Report

Market Cap: SEK 54.5m

Alligator Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATORX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4,686,41410.7%
Individual Insiders5,854,03213.4%
Institutions7,134,28016.3%
General Public26,138,94659.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 5679.9%.

Top Shareholders

Top 18 shareholders own 40.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.04%
Avanza Fonder AB
3,962,253SEK 4.9m-0.38%no data
7.84%
Hans-Peter Ostler
3,435,340SEK 4.3m491,000%no data
4.66%
Nordnet Pensionsförsäkring AB
2,042,595SEK 2.5m9.96%0.03%
4.06%
Roxette Photo S.A.
1,780,000SEK 2.2m-10.4%no data
2.83%
Johan Zetterstedt
1,238,800SEK 1.5m0%no data
2.65%
Sbakkejord AS
1,160,000SEK 1.4m0%no data
1.86%
Aktiebolaget Gryningsstunden FÖRvaltning
815,164SEK 1.0m0%no data
1.83%
Morgan Stanley
800,000SEK 995.5k0%no data
1.63%
Jonas Sjogren
714,516SEK 889.1k13,500%no data
1.14%
Pearla Gem Ltd
500,000SEK 622.2k0%no data
1.07%
Niklas Borgquist
470,000SEK 584.9k0%no data
0.98%
Zetterstedt Holding AB
431,250SEK 536.6k0%no data
0.57%
Allegro Investment Inc.
249,949SEK 311.0k0%0.12%
0.25%
SEB Investment Management AB
107,643SEK 133.9k5,350%no data
0.02%
Handelsbanken Asset Management
8,948SEK 11.1k0%no data
0.0061%
FCG Fonder AB
2,669SEK 3.3k0%no data
0.0012%
Storebrand Fonder AB,
532SEK 659.70%no data
0.00021%
Skandia Fonder AB
94SEK 114.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/27 14:34
End of Day Share Price 2025/10/24 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alligator Bioscience AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carl RamaniusRedeye
Filip LindkvistRedeye